Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-17-010873
Filing Date
2017-10-24
Accepted
2017-10-24 16:31:58
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS f424b31017shelf_actinium.htm 424B3 438914
2 GRAPHIC img_01.jpg GRAPHIC 25442
3 GRAPHIC img_02.jpg GRAPHIC 25442
  Complete submission text file 0001213900-17-010873.txt   510326
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-216748 | Film No.: 171151244
SIC: 2834 Pharmaceutical Preparations